Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 17Melanoma 15Head and Neck Neoplasms 15Carcinoma, Renal Cell 12Carcinoma, Non-Small-Cell Lung 12Stomach Neoplasms 8Uterine Cervical Neoplasms 7Neoplasms 7Colorectal Neoplasms 7Carcinoma, Transitional Cell 6Carcinoma, Hepatocellular 6Urinary Bladder Neoplasms 5Triple Negative Breast Neoplasms 5Carcinoma, Merkel Cell 5Pancreatic Neoplasms 4Ovarian Neoplasms 4Kidney Neoplasms 4Carcinoma, Squamous Cell 4Breast Neoplasms 4Small Cell Lung Carcinoma 3Esophageal Neoplasms 3Urogenital Neoplasms 2Thyroid Carcinoma, Anaplastic 2Sarcoma 2Oropharyngeal Neoplasms 2Nasopharyngeal Carcinoma 2Microsatellite Instability 2Mesothelioma, Malignant 2Mesothelioma 2Gastrointestinal Neoplasms 2

Interventions

atezolizumab 1Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anal Canal Carcinoma × atezolizumab × Head & Neck × Clear all
NCT03946358 2024-12-20

VolATIL

Centre Hospitalier Universitaire de Besancon

Phase 2 Completed
47 enrolled
GastrointestinalGynecologicHead & Neck

Anal Canal Carcinoma, Squamous Cell Carcinoma of Head and Neck, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡